From ALAN SCOTT
As a person suffering from a chronic antibody deficiency (hypogammaglobulinaemia)
I was very interested to read your feature on the clinical uses of antibodies
(‘A second chance for antibodies’, 9 February). As ever with such articles
I was puzzled to find no mention of the fact that patients like myself have
been treated successfully with antibodies from pooled plasma for more than
30 years or that developments like the ones you describe may be important
for us.
We get good general protection from our treatment, but to receive antibodies
tailored to specifically troublesome organisms would solve significant problems
for us and almost certainly be life-saving in some cases.
Alan Scott Lewes East Sussex
